These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 32324152)

  • 1. Glycan-specific antibodies as potential cancer biomarkers: a focus on microarray applications.
    Tikhonov A; Smoldovskaya O; Feyzkhanova G; Kushlinskii N; Rubina A
    Clin Chem Lab Med; 2020 Sep; 58(10):1611-1622. PubMed ID: 32324152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overview of Characterizing Cancer Glycans with Lectin-Based Analytical Methods.
    Pearson AJ; Gallagher ES
    Methods Mol Biol; 2019; 1928():389-408. PubMed ID: 30725466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiplexed analysis of glycan variation on native proteins captured by antibody microarrays.
    Chen S; LaRoche T; Hamelinck D; Bergsma D; Brenner D; Simeone D; Brand RE; Haab BB
    Nat Methods; 2007 May; 4(5):437-44. PubMed ID: 17417647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Application of glycan microarrays in cancer research].
    Xu B; Liu Y; Xie Y
    Sheng Wu Gong Cheng Xue Bao; 2020 Nov; 36(11):2313-2326. PubMed ID: 33244926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies against aberrant glycans as cancer biomarkers.
    Blsakova A; Kveton F; Kasak P; Tkac J
    Expert Rev Mol Diagn; 2019 Dec; 19(12):1057-1068. PubMed ID: 31665948
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum antibody screening by surface plasmon resonance using a natural glycan microarray.
    de Boer AR; Hokke CH; Deelder AM; Wuhrer M
    Glycoconj J; 2008 Jan; 25(1):75-84. PubMed ID: 18193481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycan microarrays: powerful tools for biomarker discovery.
    Muthana SM; Gildersleeve JC
    Cancer Biomark; 2014 Jan; 14(1):29-41. PubMed ID: 24643040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbe-focused glycan array screening platform.
    Geissner A; Reinhardt A; Rademacher C; Johannssen T; Monteiro J; Lepenies B; Thépaut M; Fieschi F; Mrázková J; Wimmerova M; Schuhmacher F; Götze S; Grünstein D; Guo X; Hahm HS; Kandasamy J; Leonori D; Martin CE; Parameswarappa SG; Pasari S; Schlegel MK; Tanaka H; Xiao G; Yang Y; Pereira CL; Anish C; Seeberger PH
    Proc Natl Acad Sci U S A; 2019 Feb; 116(6):1958-1967. PubMed ID: 30670663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemically-blocked antibody microarray for multiplexed high-throughput profiling of specific protein glycosylation in complex samples.
    Lu C; Wonsidler JL; Li J; Du Y; Block T; Haab B; Chen S
    J Vis Exp; 2012 May; (63):e3791. PubMed ID: 22588202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deciphering disease through glycan codes: leveraging lectin microarrays for clinical insights.
    Yang H; Lin Z; Wu B; Xu J; Tao SC; Zhou S
    Acta Biochim Biophys Sin (Shanghai); 2024 Aug; 56(8):1145-1155. PubMed ID: 39099413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered glycosylation in cancer: A promising target for biomarkers and therapeutics.
    Thomas D; Rathinavel AK; Radhakrishnan P
    Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188464. PubMed ID: 33157161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of microarrays for deciphering the structure and function of the human glycome.
    Smith DF; Cummings RD
    Mol Cell Proteomics; 2013 Apr; 12(4):902-12. PubMed ID: 23412570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbohydrate microarrays for enzymatic reactions and quantification of binding affinities for glycan-protein interactions.
    Lee MR; Park S; Shin I
    Methods Mol Biol; 2012; 808():103-16. PubMed ID: 22057520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum antibodies to blood group A predict survival on PROSTVAC-VF.
    Campbell CT; Gulley JL; Oyelaran O; Hodge JW; Schlom J; Gildersleeve JC
    Clin Cancer Res; 2013 Mar; 19(5):1290-9. PubMed ID: 23362327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative O-glycomics based on improvement of the one-pot method for nonreductive O-glycan release and simultaneous stable isotope labeling with 1-(d
    Wang C; Zhang P; Jin W; Li L; Qiang S; Zhang Y; Huang L; Wang Z
    J Proteomics; 2017 Jan; 150():18-30. PubMed ID: 27585995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of Lectin Microarrays for Biomarker Discovery.
    Dang K; Zhang W; Jiang S; Lin X; Qian A
    ChemistryOpen; 2020 Mar; 9(3):285-300. PubMed ID: 32154049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant glycosylation as biomarker for cancer: focus on CD43.
    Tuccillo FM; de Laurentiis A; Palmieri C; Fiume G; Bonelli P; Borrelli A; Tassone P; Scala I; Buonaguro FM; Quinto I; Scala G
    Biomed Res Int; 2014; 2014():742831. PubMed ID: 24689054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum antibody screening using glycan arrays.
    Marglous S; Brown CE; Padler-Karavani V; Cummings RD; Gildersleeve JC
    Chem Soc Rev; 2024 Mar; 53(5):2603-2642. PubMed ID: 38305761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycans as cancer biomarkers.
    Adamczyk B; Tharmalingam T; Rudd PM
    Biochim Biophys Acta; 2012 Sep; 1820(9):1347-53. PubMed ID: 22178561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isomer-specific profiling of N-glycans derived from human serum for potential biomarker discovery in pancreatic cancer.
    Liu Y; Wang C; Wang R; Wu Y; Zhang L; Liu BF; Cheng L; Liu X
    J Proteomics; 2018 Jun; 181():160-169. PubMed ID: 29674015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.